Actin polymerization in neutrophils from donors of peripheral blood stem cells: Divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony‐stimulating factor

Neutrophil functions can be modified by Recombinant human G‐CSF (rhG‐CSF) treatment, with divergent effects on phagocytosis, motility, bactericidal activity, and surface molecule expression. Neutrophil morphology is modified by treatment with filgrastim (the nonglycosylated form of rhG‐CSF), while i...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of hematology Vol. 81; no. 5; pp. 318 - 323
Main Authors Carulli, Giovanni, Mattii, Letizia, Azzarà, Antonio, Brizzi, Stefania, Galimberti, Sara, Zucca, Alessandra, Benedetti, Edoardo, Petrini, Mario
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.05.2006
Wiley-Liss
Subjects
Online AccessGet full text
ISSN0361-8609
1096-8652
DOI10.1002/ajh.20604

Cover

Abstract Neutrophil functions can be modified by Recombinant human G‐CSF (rhG‐CSF) treatment, with divergent effects on phagocytosis, motility, bactericidal activity, and surface molecule expression. Neutrophil morphology is modified by treatment with filgrastim (the nonglycosylated form of rhG‐CSF), while it is not affected by lenograstim (the glycosylated type of rhG‐CSF). Little information is available about actin polymerization in neutrophils from subjects treated with the two types of rhG‐CSF. In the current paper we evaluated two groups of donors of peripheral blood stem cells (PBSC) for allogeneic transplantation. Ten subjects were treated with filgrastim and 10 with lenograstim to mobilize PBSC; 15 blood donors were evaluated as a control group. Actin polymerization (both spontaneous and fMLP‐stimulated) was studied by a flow cytometric assay. A microscopic fluorescent assay was also carried out to evaluate F‐actin distribution in neutrophils. We found that filgrastim induced an increased F‐actin content in resting neutrophils, along with morphologic evidence for increased actin polymerization distributed principally at the cell membrane and frequently polarized in focal areas; in addition, fMLP was not able to induce further actin polymerization. On the contrary, treatment with lenograstim was associated with F‐actin content, distribution, and polymerization kinetics indistinguishable from those displayed by control neutrophils. Such experimental results show that filgrastim and lenograstim display divergent effects also on neutrophil actin polymerization and provide further explanation for previous experimental findings. Am. J. Hematol. 81:318–323, 2006. © 2006 Wiley‐Liss, Inc.
AbstractList Neutrophil functions can be modified by Recombinant human G-CSF (rhG-CSF) treatment, with divergent effects on phagocytosis, motility, bactericidal activity, and surface molecule expression. Neutrophil morphology is modified by treatment with filgrastim (the nonglycosylated form of rhG-CSF), while it is not affected by lenograstim (the glycosylated type of rhG-CSF). Little information is available about actin polymerization in neutrophils from subjects treated with the two types of rhG-CSF. In the current paper we evaluated two groups of donors of peripheral blood stem cells (PBSC) for allogeneic transplantation. ten subjects were treated with filgrastim and 10 with lenograstim to mobilize PBSC; 15 blood donors were evaluated as a control group. Actin polymerization (both spontaneous and fMLP-stimulated) was studied by a flow cytometric assay. A microscopic fluorescent assay was also carried out to evaluate F-actin distribution in neutrophils. We found that filgrastim induced an increased F- actin content in resting neutrophils, along with morphologic evidence for increased actin polymerization distributed principally at the cell membrane and frequently polarized in focal areas; in addition, fMLP was not able to induce further actin polymerization. On the contrary, treatment with lenograstim was associated with F-actin content, distribution, and polymerization kinetics indistinguishable from those displayed by control neutrophils. Such experimental results show that filgrastim and lenograstim display divergent effects also on neutrophil actin polymerization and provide further explanation for previous experimental findings. Am. J. Hematol. 81:318-323, 2006.
Neutrophil functions can be modified by Recombinant human G-CSF (rhG-CSF) treatment, with divergent effects on phagocytosis, motility, bactericidal activity, and surface molecule expression. Neutrophil morphology is modified by treatment with filgrastim (the nonglycosylated form of rhG-CSF), while it is not affected by lenograstim (the glycosylated type of rhG-CSF). Little information is available about actin polymerization in neutrophils from subjects treated with the two types of rhG-CSF. In the current paper we evaluated two groups of donors of peripheral blood stem cells (PBSC) for allogeneic transplantation. Ten subjects were treated with filgrastim and 10 with lenograstim to mobilize PBSC; 15 blood donors were evaluated as a control group. Actin polymerization (both spontaneous and fMLP-stimulated) was studied by a flow cytometric assay. A microscopic fluorescent assay was also carried out to evaluate F-actin distribution in neutrophils. We found that filgrastim induced an increased F-actin content in resting neutrophils, along with morphologic evidence for increased actin polymerization distributed principally at the cell membrane and frequently polarized in focal areas; in addition, fMLP was not able to induce further actin polymerization. On the contrary, treatment with lenograstim was associated with F-actin content, distribution, and polymerization kinetics indistinguishable from those displayed by control neutrophils. Such experimental results show that filgrastim and lenograstim display divergent effects also on neutrophil actin polymerization and provide further explanation for previous experimental findings.Neutrophil functions can be modified by Recombinant human G-CSF (rhG-CSF) treatment, with divergent effects on phagocytosis, motility, bactericidal activity, and surface molecule expression. Neutrophil morphology is modified by treatment with filgrastim (the nonglycosylated form of rhG-CSF), while it is not affected by lenograstim (the glycosylated type of rhG-CSF). Little information is available about actin polymerization in neutrophils from subjects treated with the two types of rhG-CSF. In the current paper we evaluated two groups of donors of peripheral blood stem cells (PBSC) for allogeneic transplantation. Ten subjects were treated with filgrastim and 10 with lenograstim to mobilize PBSC; 15 blood donors were evaluated as a control group. Actin polymerization (both spontaneous and fMLP-stimulated) was studied by a flow cytometric assay. A microscopic fluorescent assay was also carried out to evaluate F-actin distribution in neutrophils. We found that filgrastim induced an increased F-actin content in resting neutrophils, along with morphologic evidence for increased actin polymerization distributed principally at the cell membrane and frequently polarized in focal areas; in addition, fMLP was not able to induce further actin polymerization. On the contrary, treatment with lenograstim was associated with F-actin content, distribution, and polymerization kinetics indistinguishable from those displayed by control neutrophils. Such experimental results show that filgrastim and lenograstim display divergent effects also on neutrophil actin polymerization and provide further explanation for previous experimental findings.
Neutrophil functions can be modified by Recombinant human G‐CSF (rhG‐CSF) treatment, with divergent effects on phagocytosis, motility, bactericidal activity, and surface molecule expression. Neutrophil morphology is modified by treatment with filgrastim (the nonglycosylated form of rhG‐CSF), while it is not affected by lenograstim (the glycosylated type of rhG‐CSF). Little information is available about actin polymerization in neutrophils from subjects treated with the two types of rhG‐CSF. In the current paper we evaluated two groups of donors of peripheral blood stem cells (PBSC) for allogeneic transplantation. Ten subjects were treated with filgrastim and 10 with lenograstim to mobilize PBSC; 15 blood donors were evaluated as a control group. Actin polymerization (both spontaneous and fMLP‐stimulated) was studied by a flow cytometric assay. A microscopic fluorescent assay was also carried out to evaluate F‐actin distribution in neutrophils. We found that filgrastim induced an increased F‐actin content in resting neutrophils, along with morphologic evidence for increased actin polymerization distributed principally at the cell membrane and frequently polarized in focal areas; in addition, fMLP was not able to induce further actin polymerization. On the contrary, treatment with lenograstim was associated with F‐actin content, distribution, and polymerization kinetics indistinguishable from those displayed by control neutrophils. Such experimental results show that filgrastim and lenograstim display divergent effects also on neutrophil actin polymerization and provide further explanation for previous experimental findings. Am. J. Hematol. 81:318–323, 2006. © 2006 Wiley‐Liss, Inc.
Neutrophil functions can be modified by Recombinant human G-CSF (rhG-CSF) treatment, with divergent effects on phagocytosis, motility, bactericidal activity, and surface molecule expression. Neutrophil morphology is modified by treatment with filgrastim (the nonglycosylated form of rhG-CSF), while it is not affected by lenograstim (the glycosylated type of rhG-CSF). Little information is available about actin polymerization in neutrophils from subjects treated with the two types of rhG-CSF. In the current paper we evaluated two groups of donors of peripheral blood stem cells (PBSC) for allogeneic transplantation. Ten subjects were treated with filgrastim and 10 with lenograstim to mobilize PBSC; 15 blood donors were evaluated as a control group. Actin polymerization (both spontaneous and fMLP-stimulated) was studied by a flow cytometric assay. A microscopic fluorescent assay was also carried out to evaluate F-actin distribution in neutrophils. We found that filgrastim induced an increased F-actin content in resting neutrophils, along with morphologic evidence for increased actin polymerization distributed principally at the cell membrane and frequently polarized in focal areas; in addition, fMLP was not able to induce further actin polymerization. On the contrary, treatment with lenograstim was associated with F-actin content, distribution, and polymerization kinetics indistinguishable from those displayed by control neutrophils. Such experimental results show that filgrastim and lenograstim display divergent effects also on neutrophil actin polymerization and provide further explanation for previous experimental findings.
Author Galimberti, Sara
Benedetti, Edoardo
Zucca, Alessandra
Carulli, Giovanni
Azzarà, Antonio
Mattii, Letizia
Brizzi, Stefania
Petrini, Mario
Author_xml – sequence: 1
  givenname: Giovanni
  surname: Carulli
  fullname: Carulli, Giovanni
  email: g.carulli@ao‐pisa.toscana.it
– sequence: 2
  givenname: Letizia
  surname: Mattii
  fullname: Mattii, Letizia
– sequence: 3
  givenname: Antonio
  surname: Azzarà
  fullname: Azzarà, Antonio
– sequence: 4
  givenname: Stefania
  surname: Brizzi
  fullname: Brizzi, Stefania
– sequence: 5
  givenname: Sara
  surname: Galimberti
  fullname: Galimberti, Sara
– sequence: 6
  givenname: Alessandra
  surname: Zucca
  fullname: Zucca, Alessandra
– sequence: 7
  givenname: Edoardo
  surname: Benedetti
  fullname: Benedetti, Edoardo
– sequence: 8
  givenname: Mario
  surname: Petrini
  fullname: Petrini, Mario
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17803535$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16628714$$D View this record in MEDLINE/PubMed
BookMark eNqFks9u1DAQxi1URLeFAy-AfAGJw7bjJOsk3FblT0GVuMDZcuzJrivHDrZTFE48Am_Eu_AkuLsLCATi5NHo933yzHwn5Mh5h4Q8ZHDGAIpzeb09K4BDdYcsGLR82fBVcUQWUHKWa2iPyUmM1wCMVQ3cI8eM86KpWbUgX9cqGUdHb-cBg_kkk_GO5o7DKQU_bo2NtA9-oNo7HyL1PR0zOG4xSEs7672mMeFAFVobn9Hn5gbDBl2i2Peo0k6xsbPycbYyoabSaZoH-K0XUPmhM05m3XYapKObIN1kvZoTUuWtd_O3z19iMsOUFcZtaC9V8uE-udtLG_HB4T0l71--eHdxubx6--r1xfpqqSrWVktdo2wKDVXV1R3UHNtilVfRVawsmhKBoV6VK6VrqNpO1joXta46JjmwUjVFeUqe7H3H4D9MGJMYTLwdWTr0UxS8brMtNP8FWdty4CuWwUcHcOoG1GIMZpBhFj9uk4HHB0BGJW2fF6JM_MXVDZT505k733Mq-BgD9kKZtLtjCtJYwUDcpkTklIhdSrLi6R-Kn6Z_YQ_uH43F-d-gWL-53Cu-A57a0Xg
CODEN AJHEDD
CitedBy_id crossref_primary_10_1016_j_vetimm_2012_11_001
crossref_primary_10_1016_j_leukres_2006_11_016
crossref_primary_10_1111_j_1537_2995_2007_01241_x
crossref_primary_10_2165_11206870_000000000_00000
crossref_primary_10_1016_j_leukres_2010_10_029
crossref_primary_10_1016_j_leukres_2010_05_027
crossref_primary_10_1111_trf_14533
crossref_primary_10_1189_jlb_0207090
crossref_primary_10_1517_14712591003689964
crossref_primary_10_3389_fimmu_2019_01632
crossref_primary_10_3892_or_2012_2061
crossref_primary_10_1016_j_ajpath_2015_09_008
Cites_doi 10.1016/S0022-1759(99)00168-4
10.1046/j.1365-2141.1996.00295.x
10.1002/ajh.1064
10.1016/S0955-0674(02)00310-1
10.1038/sj.bmt.1703136
10.1016/S0145-2126(97)00009-X
10.1002/jcb.20248
10.1182/blood.V81.10.2750.2750
10.1016/S1357-2725(03)00144-4
10.1177/154411130201300302
10.1182/blood.V92.11.4366
10.1111/j.1365-2362.1995.tb01969.x
10.1046/j.1365-2141.1997.d01-2029.x
10.1185/030079903125002531
10.2165/00003495-200059030-00017
10.1111/j.1365-2141.2004.05008.x
10.1097/00001813-200103000-00002
10.1083/jcb.101.3.1078
ContentType Journal Article
Copyright Copyright © 2006 Wiley‐Liss, Inc.
2006 INIST-CNRS
2006 Wiley-Liss, Inc.
Copyright_xml – notice: Copyright © 2006 Wiley‐Liss, Inc.
– notice: 2006 INIST-CNRS
– notice: 2006 Wiley-Liss, Inc.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7T5
8FD
FR3
H94
P64
7X8
DOI 10.1002/ajh.20604
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Immunology Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE - Academic

MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1096-8652
EndPage 323
ExternalDocumentID 16628714
17803535
10_1002_ajh_20604
AJH20604
Genre article
Randomized Controlled Trial
Journal Article
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
23M
24P
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDPE
ABEML
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHMBA
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EBS
EGARE
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IH2
IX1
J0M
J5H
JPC
KBYEO
KD1
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6P
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
P6G
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
TEORI
TR2
UB1
V2E
V8K
VH1
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
X7M
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7T5
8FD
FR3
H94
P64
7X8
ID FETCH-LOGICAL-c4194-d7ea82d044b7b076e925480b413283e01ed535cd7049ba7dd707d4b1a6013c823
IEDL.DBID DR2
ISSN 0361-8609
IngestDate Fri Jul 11 07:05:36 EDT 2025
Fri Jul 11 00:57:04 EDT 2025
Wed Feb 19 01:52:48 EST 2025
Mon Jul 21 09:11:49 EDT 2025
Tue Jul 01 01:31:35 EDT 2025
Thu Apr 24 23:12:26 EDT 2025
Wed Jan 22 16:26:38 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Hematology
rhG-CSF
Granulocyte
Hematopoietic cell
Polymerization
Contractile protein
Glycosylation
Human factor
actin polymerization
Granulocyte colony stimulating factor
Actin
Neutrophil
Recombinant protein
neutrophils
Blood donor
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
2006 Wiley-Liss, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4194-d7ea82d044b7b076e925480b413283e01ed535cd7049ba7dd707d4b1a6013c823
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.20604
PMID 16628714
PQID 19960651
PQPubID 23462
PageCount 6
ParticipantIDs proquest_miscellaneous_67907608
proquest_miscellaneous_19960651
pubmed_primary_16628714
pascalfrancis_primary_17803535
crossref_citationtrail_10_1002_ajh_20604
crossref_primary_10_1002_ajh_20604
wiley_primary_10_1002_ajh_20604_AJH20604
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate May 2006
PublicationDateYYYYMMDD 2006-05-01
PublicationDate_xml – month: 05
  year: 2006
  text: May 2006
PublicationDecade 2000
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
– name: New York, NY
– name: United States
PublicationTitle American journal of hematology
PublicationTitleAlternate Am J Hematol
PublicationYear 2006
Publisher Wiley Subscription Services, Inc., A Wiley Company
Wiley-Liss
Publisher_xml – name: Wiley Subscription Services, Inc., A Wiley Company
– name: Wiley-Liss
References 2004; 99
2002; 14
2004; 126
1997; 82
1995; 80
2000; 59
1997; 21
1997; 96
1995; 25
1993; 81
2003; 35
2003; 13
1985; 101
1997
1998; 92
1996; 92
2001; 28
2003; 19
1999; 232
2001; 66
2001; 12
Carulli G (e_1_2_1_4_2) 1995; 80
e_1_2_1_7_2
Leavy PJ (e_1_2_1_6_2) 1998; 92
Carulli G (e_1_2_1_3_2) 1997; 82
e_1_2_1_5_2
e_1_2_1_2_2
e_1_2_1_11_2
e_1_2_1_22_2
e_1_2_1_20_2
e_1_2_1_10_2
e_1_2_1_21_2
e_1_2_1_15_2
e_1_2_1_16_2
e_1_2_1_13_2
e_1_2_1_14_2
e_1_2_1_19_2
Azzarà A (e_1_2_1_12_2) 1997
e_1_2_1_8_2
e_1_2_1_17_2
e_1_2_1_9_2
e_1_2_1_18_2
References_xml – volume: 19
  start-page: 753
  year: 2003
  end-page: 759
  article-title: Comparison of lenograstim and filgrastim on haematological effects after autologous peripheral blood stem cell transplantation with high‐dose therapy
  publication-title: Curr Med Res Opin
– volume: 12
  start-page: 185
  year: 2001
  end-page: 191
  article-title: Granulocyte colony‐stimulating factors: how different are they? How to make a decision?
  publication-title: Anticancer Drugs
– start-page: 504
  year: 1997
  end-page: 505
  article-title: Morphological features following G‐CSF treatment
  publication-title: Haematologica
– volume: 92
  start-page: 4366
  year: 1998
  end-page: 4374
  article-title: In vivo treatment with granulocyte colony‐stimulating factor results in divergent effects on neutrophil functions measured in vitro
  publication-title: Blood
– volume: 13
  start-page: 220
  year: 2003
  end-page: 228
  article-title: Chemotactic signaling pathways in neutrophils: from receptor to actin assembly
  publication-title: Crit Rev Oral Biol Med
– volume: 28
  start-page: 259
  year: 2001
  end-page: 264
  article-title: Glycosylated vs non‐glycosylated granulocyte colony‐stimulating factor (G‐CSF)—results of a prospective randomised monocentre study
  publication-title: Bone Marrow Transplant
– volume: 59
  start-page: 681
  year: 2000
  end-page: 717
  article-title: lenograstim: an update of its pharmacological properties and use in chemotherapy‐induced neutropenia and related clinical settings
  publication-title: Drugs
– volume: 21
  start-page: 513
  year: 1997
  end-page: 518
  article-title: Actin polymerization in neutrophils from patients affected by myelodysplastic syndromes. A flow cytometric study
  publication-title: Leukemia Res
– volume: 80
  start-page: 150
  year: 1995
  end-page: 154
  article-title: Granulocyte colony‐stimulating factor increases CD32 (FcRII) expression and FcR‐related functions
  publication-title: Haematologica
– volume: 99
  start-page: 1231
  year: 2004
  end-page: 1241
  article-title: Carboxy‐terminal fragment of osteogenic growth peptide regulates myeloid differentiation through RhoA
  publication-title: J Cell Biochem
– volume: 14
  start-page: 196
  year: 2002
  end-page: 202
  article-title: Regulation of cell polarity during eukaryotic chemotaxis: the chemotactic compass
  publication-title: Curr Opin Cell Biol
– volume: 66
  start-page: 306
  year: 2001
  end-page: 307
  article-title: lenograstim and filgrastim effects on neutrophil motility in patients undergoing chemotherapy: evaluation by computer‐assisted image analysis
  publication-title: Am J Hematol
– volume: 35
  start-page: 1619
  year: 2003
  end-page: 1638
  article-title: Signaling to migration in neutrophils: importance of localized pathways
  publication-title: Int J Biochem Cell Biol
– volume: 82
  start-page: 606
  year: 1997
  end-page: 616
  article-title: Effects of recombinant human granulocyte colony‐stimulating factor administration on neutrophil phenotype and function
  publication-title: Haematologica
– volume: 81
  start-page: 2750
  year: 1993
  end-page: 2757
  article-title: Mechanisms for actin reorganization in chemotactic factor‐activated polymorphonuclear leukocytes
  publication-title: Blood
– volume: 25
  start-page: 929
  year: 1995
  end-page: 938
  article-title: Interactions between platelets and neutrophils in essential thrombocythemia. Effects on neutrophil chemiluminescence and superoxide anion generation
  publication-title: Eur J Clin Invest
– volume: 96
  start-page: 418
  year: 1997
  end-page: 420
  article-title: Prospective randomized study comparing the efficacy of bioequivalent doses of glycosylated and nonglycosylated rG‐CSF for mobilizing peripheral blood progenitor cells
  publication-title: Br J Haematol
– volume: 92
  start-page: 161
  year: 1996
  end-page: 168
  article-title: Motility of rhG‐CSF‐induced neutrophils in patients undergoing chemotherapy: evidence for inhibition detected by image analysis
  publication-title: Br J Haematol
– volume: 101
  start-page: 1078
  year: 1985
  end-page: 1085
  article-title: The kinetics of chemotactic peptide‐induced change in F‐actin content, F‐actin distribution, and the shape of neutrophils
  publication-title: J Cell Biol
– volume: 232
  start-page: 89
  year: 1999
  end-page: 109
  article-title: Function of the cytoskeleton in human neutrophils and methods for evaluation
  publication-title: J Immunol Methods
– volume: 126
  start-page: 127
  year: 2004
  end-page: 132
  article-title: Efficacy and safety of two different rG‐CSF preparations in the treatment of patients with severe congenital neutropenia
  publication-title: Br J Haematol
– ident: e_1_2_1_22_2
  doi: 10.1016/S0022-1759(99)00168-4
– ident: e_1_2_1_5_2
  doi: 10.1046/j.1365-2141.1996.00295.x
– volume: 80
  start-page: 150
  year: 1995
  ident: e_1_2_1_4_2
  article-title: Granulocyte colony‐stimulating factor increases CD32 (FcRII) expression and FcR‐related functions
  publication-title: Haematologica
– ident: e_1_2_1_13_2
  doi: 10.1002/ajh.1064
– ident: e_1_2_1_20_2
  doi: 10.1016/S0955-0674(02)00310-1
– ident: e_1_2_1_8_2
  doi: 10.1038/sj.bmt.1703136
– ident: e_1_2_1_18_2
  doi: 10.1016/S0145-2126(97)00009-X
– start-page: 504
  year: 1997
  ident: e_1_2_1_12_2
  article-title: Morphological features following G‐CSF treatment
  publication-title: Haematologica
– ident: e_1_2_1_19_2
  doi: 10.1002/jcb.20248
– ident: e_1_2_1_21_2
  doi: 10.1182/blood.V81.10.2750.2750
– ident: e_1_2_1_14_2
  doi: 10.1016/S1357-2725(03)00144-4
– ident: e_1_2_1_15_2
  doi: 10.1177/154411130201300302
– volume: 92
  start-page: 4366
  year: 1998
  ident: e_1_2_1_6_2
  article-title: In vivo treatment with granulocyte colony‐stimulating factor results in divergent effects on neutrophil functions measured in vitro
  publication-title: Blood
  doi: 10.1182/blood.V92.11.4366
– ident: e_1_2_1_16_2
  doi: 10.1111/j.1365-2362.1995.tb01969.x
– ident: e_1_2_1_10_2
  doi: 10.1046/j.1365-2141.1997.d01-2029.x
– ident: e_1_2_1_11_2
  doi: 10.1185/030079903125002531
– ident: e_1_2_1_7_2
  doi: 10.2165/00003495-200059030-00017
– ident: e_1_2_1_2_2
  doi: 10.1111/j.1365-2141.2004.05008.x
– volume: 82
  start-page: 606
  year: 1997
  ident: e_1_2_1_3_2
  article-title: Effects of recombinant human granulocyte colony‐stimulating factor administration on neutrophil phenotype and function
  publication-title: Haematologica
– ident: e_1_2_1_9_2
  doi: 10.1097/00001813-200103000-00002
– ident: e_1_2_1_17_2
  doi: 10.1083/jcb.101.3.1078
SSID ssj0011480
Score 1.8560717
Snippet Neutrophil functions can be modified by Recombinant human G‐CSF (rhG‐CSF) treatment, with divergent effects on phagocytosis, motility, bactericidal activity,...
Neutrophil functions can be modified by Recombinant human G-CSF (rhG-CSF) treatment, with divergent effects on phagocytosis, motility, bactericidal activity,...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 318
SubjectTerms actin
actin polymerization
Actins - metabolism
Adult
Antigens, CD34 - metabolism
Biological and medical sciences
Blood Donors
Female
Filgrastim
Flow Cytometry
Glycosylation
Granulocyte Colony-Stimulating Factor - administration & dosage
Granulocyte Colony-Stimulating Factor - pharmacology
Granulocyte Colony-Stimulating Factor - therapeutic use
Hematologic and hematopoietic diseases
Humans
Injections, Subcutaneous
Leukocyte Count
Male
Medical sciences
Microscopy, Fluorescence
Middle Aged
neutrophils
Neutrophils - cytology
Neutrophils - drug effects
Neutrophils - metabolism
Peripheral Blood Stem Cell Transplantation
Recombinant Proteins - administration & dosage
Recombinant Proteins - pharmacology
Recombinant Proteins - therapeutic use
rhG‐CSF
Title Actin polymerization in neutrophils from donors of peripheral blood stem cells: Divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony‐stimulating factor
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fajh.20604
https://www.ncbi.nlm.nih.gov/pubmed/16628714
https://www.proquest.com/docview/19960651
https://www.proquest.com/docview/67907608
Volume 81
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhh1IofSR9bB_pUErJxYkfsmy3p6VpWALpoTSQQ8FIlrx9eOVlvXtwT_0J_Uf9L_0lnZH2wZYESm_GjGxZHknfaGa-YexlWkgtciWCtNBhwBOlAhVJFRjNc1moGldEync-fy9GF_zsMr3cYW9WuTCeH2J94EYzw63XNMGl6o43pKHyK_kShOMCjRJBvPknH9bUUQTzQ--njIJchMWKVSiMj9ctt_aiW1PZ4bDUvp7FVYBzG7-6Dej0Dvu06rqPO_l2tJiro-r7X6yO__ltd9ntJTCFodeke2zH2D22P7RolE96eAUuVNSdwe-xG-dLj_w--zXEBdPCtG168v34pE7AO9Ys5rN2-vlL0wHlsIBubTvroK2ByJUdm0EDLm4eiEwayIXQvYYTChShfC9YhppQi3HTV23XNwiMNUirwbZ26x7Z9RPlonrAlR2EMY7wAnfqfm6AmLlt__vHT1zPJq5emR2DrzR0n12cvvv4dhQsi0IEFY8KHujMyDzWIecqU2EmTBETZZ3CzRiRkgkjo9MkrXSGpo-SmcaLTHPUP7Q8kyqPkwdsF_toHjFIeWXQvjTC8ITrqs5TiXisCHUtMlPFesAOV-pRVkvGdCrc0ZSe6zku8T-V7j8N2Iu16NTThFwldLClYxvJLA8T7PWAPV8pXYmznMZdWtMuupJixREsRtdLiKwgJ2s-YA-9tm6eLgSZxfj6Q6dz13ewHJ6N3MXjfxd9wm76UymKAX3KduezhXmGOG2uDtyE_AMX1j_O
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIgES4tFSWB7tCCHUS9ps4jgJ4rKiVEvp9oBaqRcUxbGzPLLOarN7CCd-Av-I_8IvYcbehxa1EuIWRePEccb2N56Zbxh7GaW5EokUXpQq3-OhlJ7s5tLTiid5KktcESnfeXAm-hf85DK63GBvFrkwjh9ieeBGM8Ou1zTB6UD6cMUamn8lZ4IgMtAbHIEGmV5HH5fkUQT0feep7HqJ8NMFr5AfHC6bru1Gd8Z5gwNTuooWV0HOdQRrt6Dje-zTovMu8uTbwWwqD4rvf_E6_u_X3Wd359gUek6ZHrANbbbYds-gXT5q4RXYaFF7DL_Fbg7mTvlt9quHa6aBcV215P5xeZ2Ad4yeTSf1-POXqgFKYwFVm3rSQF0C8StbQoMKbOg8EJ80kBeheQ1HFCtCKV8wjzahFsOqLeqmrRAbK8iNAlObtXtk2o-kDewBW3kQhjjEM9ys26kGIuc27e8fP3FJG9mSZWYIrtjQQ3Zx_O78bd-b14XwCt5NuadinSeB8jmXsfRjodOAWOsk7scIlrTf1SoKo0LFaP3IPFZ4ESuOKojGZ1gkQbjDNrGP-jGDiBcaTUwtNA-5KsokyhGSpb4qRayLQHXY_kI_smJOmk61O6rM0T0HGf6nzP6nDnuxFB07ppCrhHbXlGwlGSd-iL3usL2F1mU40Wncc6PrWZNRuDjixe71EiJOyc-adNgjp66rpwtBljG-ft8q3fUdzHonfXvx5N9F99it_vngNDt9f_bhKbvtDqkoJPQZ25xOZvo5wrap3LWz8w_jHkPt
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwELWqIlVIiEvLZbm0I4RQX9JmE8dJ4GlFWS2FVghRqQ9IURw7S0vWWW12H8ITn8Af8S98CTP2XrSolRBvUTROHGdsn_HMnGHsRZTmSiRSeFGqfI-HUnqym0tPK57kqSxxRaR855NTMTjjx-fR-QZ7vciFcfwQywM3mhl2vaYJPlbl4Yo0NL8kX4IgLtAbXCCSIET0ackdRTjfd47KrpcIP13QCvnB4bLp2mZ0a5w3OC6lK2hxFeJcB7B2B-rfYV8WfXeBJ98OZlN5UHz_i9bxPz_uLrs9R6bQc6p0j21os812egat8lELL8HGitpD-G22dTJ3ye-wXz1cMQ2M66ol54_L6gS8Y_RsOqnHXy-qBiiJBVRt6kkDdQnErmzpDCqwgfNAbNJAPoTmFRxRpAglfME81oRaDKu2qJu2QmSsIDcKTG3W7pFhP5I2rAds3UEY4gjPcKtupxqImtu0v3_8xAVtZAuWmSG4UkP32Vn_7ec3A29eFcIreDflnop1ngTK51zG0o-FTgPirJO4GyNU0n5XqyiMChWj7SPzWOFFrDgqIJqeYZEE4QO2iX3UjxhEvNBoYGqhechVUSZRjoAs9VUpYl0EqsP2F-qRFXPKdKrcUWWO7DnI8D9l9j912POl6NjxhFwltLumYyvJOPFD7HWH7S2ULsNpTuOeG13PmoyCxREtdq-XEHFKXtakwx46bV09XQiyi_H1-1bnru9g1jse2IvH_y66x7Y-HvWzD-9O3z9hN90JFcWDPmWb08lMP0PMNpW7dm7-AfcrQpw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Actin+polymerization+in+neutrophils+from+donors+of+peripheral+blood+stem+cells+%3A+Divergent+effects+of+glycosylated+and+nonglycosylated+recombinant+human+granulocyte+colony-stimulating+factor&rft.jtitle=American+journal+of+hematology&rft.au=CARULLI%2C+Giovanni&rft.au=MATTII%2C+Letizia&rft.au=AZZARA%2C+Antonio&rft.au=BRIZZI%2C+Stefania&rft.date=2006-05-01&rft.pub=Wiley-Liss&rft.issn=0361-8609&rft.volume=81&rft.issue=5&rft.spage=318&rft.epage=323&rft_id=info:doi/10.1002%2Fajh.20604&rft.externalDBID=n%2Fa&rft.externalDocID=17803535
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0361-8609&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0361-8609&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0361-8609&client=summon